US8524760B2 - HCV protease inhibitors and uses thereof - Google Patents

HCV protease inhibitors and uses thereof Download PDF

Info

Publication number
US8524760B2
US8524760B2 US13/443,847 US201213443847A US8524760B2 US 8524760 B2 US8524760 B2 US 8524760B2 US 201213443847 A US201213443847 A US 201213443847A US 8524760 B2 US8524760 B2 US 8524760B2
Authority
US
United States
Prior art keywords
ring
nitrogen
oxygen
substituted
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US13/443,847
Other versions
US20120190614A1 (en
Inventor
Deqiang Niu
Russell C. Petter
Lixin Qiao
Juswinder Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Car LLC
Original Assignee
Celgene Avilomics Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US8926908P priority Critical
Priority to US9866208P priority
Priority to US12/541,347 priority patent/US8188137B2/en
Priority to US13/443,847 priority patent/US8524760B2/en
Application filed by Celgene Avilomics Research Inc filed Critical Celgene Avilomics Research Inc
Publication of US20120190614A1 publication Critical patent/US20120190614A1/en
Assigned to AVILA THERAPEUTICS, INC. reassignment AVILA THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NIU, DEQIANG, PETTER, RUSSELL C., QIAO, LIXIN, SINGH, JUSWINDER
Assigned to CELGENE AVILOMICS RESEARCH, INC. reassignment CELGENE AVILOMICS RESEARCH, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AVILA THERAPEUTICS, INC.
Application granted granted Critical
Publication of US8524760B2 publication Critical patent/US8524760B2/en
Assigned to CELGENE CAR LLC reassignment CELGENE CAR LLC MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CELGENE AVILOMICS RESEARCH, INC., CELGENE CAR LLC
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links